chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One of the nurses, I had that administered the vaccine said she also had the chills/her nurse that gave her shot had the chills 6 hours later; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team. This Physician reported similar events for 2 patients. This is second of two reports. This Physician reported for a female patient that:  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "One of the nurses, I had that administered the vaccine said she also had the chills/her nurse that gave her shot had the chills 6 hours later".  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021379914 Same reporter/Drug/AE, Different patient
Fatigue lasting 2 days. Rash on injected arm, extending to upper torso, chest, back and lower neck. Swollen glands in neck. Bruise-like pain at injection site for 4 days when touched, with no pain when untouched.
Chills; headache; diarrhea; vomiting; body ache; received second dose BNT162B2(lot number EI1283) , intramuscular at Arm Left on 08Jan2021; received second dose BNT162B2(lot number EI1283) , intramuscular at Arm Left on 08Jan2021; This is a spontaneous report from a contactable Nurse(patient). A 36-Year-old female patient received second dose BNT162B2(lot number EI1283) , intramuscular at Arm Left on 08Jan2021 19:00 at the 36 years old at single dose for COVID-19 immunization.  The medical history included Asthma and Dm(Diabetes mellitus). The patient was not Allergies to medications, food, or other products. There were concomitant medications but unspecified. The patient previously took first dose BNT162B2 (lot numberEJ1685) on 21Dec20200 6:30 PM at 36 years old Intramuscular at Left arm for COVID-19 immunization. The patient experienced Chills, headache, diarrhea, vomiting, body ache on 09Jan2021 02:30 AM. It was unknown if there was treatment received for the adverse events Chills, headache, diarrhea, vomiting, body ache. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.  The information on the batch number has been requested.
pt recv first series of vax & did not seroconvert (titer results less than 10);
I got Shingles but had the Vx, Suspected vaccination Failure; Got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I got Shingles but had the Vx, Suspected vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles).  The outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-MAR-2023 This case was reported by the patient via interactive digital media. The reporter reported that he or she got Shingles but had the vaccine so it did not last long. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
A week after my first injection, my left arm at the injection site swelled up, was hot, red and super itchy.  This lasted about 4 days.    At three weeks after the injection under my eyes swelled up, was red and super itchy.  It felt like a chemical burn.  I used no new products.
2 days ago noticed redness and itching at the injection site of left upper arm.  Some tenderness to left axillary lymph node area.  No swelling in the lymph node.  Area outlined and being monitored.  No noticeable lump on the arm.
While working with a patient she suddenly started to itch on her face and her eyeballs. She developed some blotch areas on her body. Looks a little flushed. States that she has many allergies and that with previous flu vaccines have made her feel ill. She had a Benydral tablet which she took at 8:20 this morning. I spoke with her at 8:55 a.m. and she is feeling a little better.
Dizziness; Left eye swelling; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), EYE SWELLING (Left eye swelling) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010W20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced DIZZINESS (Dizziness), EYE SWELLING (Left eye swelling) and NAUSEA (nausea). At the time of the report, DIZZINESS (Dizziness) had resolved and EYE SWELLING (Left eye swelling) and NAUSEA (nausea) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medication included Tylenol. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Patient reported having a sore throat with a "weird taste" in her mouth. She said she also had trouble swallowing. She went to see her primary doctor and was treated for her reactions. She is ok now.
Joint pain lasting over 6 weeks.  Heart palpitations  lasting over 4 weeks.
weak; tired/Worn out; Pain off and on/It literally wiped me out; Terrific pain in my upper chest; It started in my back/went to my front from the waist up; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Terrific pain in my upper chest), BACK PAIN (It started in my back/went to my front from the waist up), ASTHENIA (weak), PAIN (Pain off and on/It literally wiped me out) and FATIGUE (tired/Worn out) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C214, 025L20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Oct-2021, the patient experienced CHEST PAIN (Terrific pain in my upper chest), BACK PAIN (It started in my back/went to my front from the waist up) and PAIN (Pain off and on/It literally wiped me out). On an unknown date, the patient experienced ASTHENIA (weak). an unknown date, the patient experienced FATIGUE (tired/Worn out). At the time of the report, CHEST PAIN (Terrific pain in my upper chest), BACK PAIN (It started in my back/went to my front from the waist up), ASTHENIA (weak), PAIN (Pain off and on/It literally wiped me out) and FATIGUE (tired/Worn out) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Chest X-ray: normal (normal) Normal. On an unknown date, Computerised tomogram: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.  The patient had heart monitor test, blood draw whose result were Normal.   This case was linked to MOD-2021-374774 (Patient Link).
Mild, localized, superficial, cellulitis around the administration site in the thigh. Mild tenderness and no systemic symptoms.  Was given antibiotics (Cefadroxil) for two days with complete resolution.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient had delivered a baby on an unspecified date. On 30-JAN-2014 the patient was vaccinated with a dose of PNEUMOVAX23 (lot# J013345, expiry date: 11-JAN-2015) dose, route and location unspecified. After 14 hours the vaccination the patient developed "excruciating pain, that made the patient cry," unspecified swelling, overall weakness and patient's legs gave out as she was leaving the hospital (on an unspecified date). Pharmacist requested a lot check for this PNEUMOVAX23. At the time of the report, the outcome of the events were unknown. This is one of several reports received from the same reporter. Additional information has been requested.
This is a spontaneous report from a contactable physician via a colleague. This physician reported that a female patient received PREVNAR13, 0.5 ml, single dose on an unknown date and developed a painful rash and erythema 3 x 3 of diameter on left deltoid. The patient reported the event 48 hours after the administration. The outcome of the events was unknown.
A diagnosis of bronchialitis and pneumonia were given within 2 days of a HepB Vaccination.  My son could not breathe.  He was cyanotic, coughing hard and vomiting coupiously.  His O2 sat in the hospital ER was less than 85.  During his hospital stay, the first three days RSV was considered as a possible dx.  It was not RSV.  During his hospital stay, blood gases were taken every four hours as was treatment with inhalation albuterol and resemic epenephrine.  He was also given steriods as well as abx.  He was completely breastfed.  No formula or water given.  My healthy babe was made very ill.  Within 10 months of his initial hospital visit, he suffered a second onset of pneumonia (no hospitalization  required) with a tempature of 107 at home and 105.9 in the ER.  He was diagnosed with asthma within three months of the second case of pneumonia.
menstruation restarted after menopause for 8 months; This is a spontaneous report from a contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 09Mar2021 at 12:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient was known to be allergic to sulfa. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 16Feb2021 at 10:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 09:00 exactly two weeks after receiving the second dose of vaccination, the patient's menstruation restarted after being menopause for 8 months. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event menstruation restarted after being menopause for 8 months was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
After receiving the vaccine, I went home and took a nap. 2 hours later, I woke up and was very sick.I was experiencing pain rash all over body, soreness, swelling, headache, muscle aches,fatigue, nausea, stomach pain, I was hurting all over my body. Four days later, I went to the doctor, she told me that, I had a very severe reaction to shingles vaccine, and prescribed BENADRYL. I ended up in the emergency room, a week later, and needed more BENADRYL. I was back in the emergency room in 2 days, again I needed BENADRYL. I was not aware that my body and mind had been affected, so badly by vaccine injection. I saw my doctor and now I have to take BENADRYL and CLARITIN all the time.  I have a very hard time mentally, to remember anything, like I did before vaccine injection. I was lucky, I did not die from it! My body is so bad with allergies now, that I have to be tested to see, what medication I will have to be on, in the future.
2nd dose not received yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 2nd dose not received yet).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 23-AUG-2023 A pharmacist reported that a male patient received the 1st dose of Shingrix in 2019 and is late for the 2nd dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up via email. The reporter did not have patient or vaccination details at the time of report.
Fatigue, water retention - in feet/legs and lungs resulting in A-fib. These symptoms continued for weeks. After seeing PCP on March22, 2021, I began taking lasix and potassium for swelling. After seeing cardiologist on April 1, 2021, I began taking Eliquis, entresto and metoprolol. My heart is now back in sinus rhythm. The "pumpability" of the heart in March 30, 2021 echocardiogram registered at 20 (should be 50 or above). A follow up pet scan on April 16, 2021 show it improved to 35.
a little weak; Sleepy; nauseas; Fever; they had a miserable night; Sick whole day and night; Had a night sweat; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021. The most recent information was received on 04-Aug-2021 and was forwarded to Moderna on 04-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (they had a miserable night), ILLNESS (Sick whole day and night), NIGHT SWEATS (Had a night sweat), SOMNOLENCE (Sleepy) and ASTHENIA (a little weak) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient was infected with Covid-19 on 06-Feb-2021, and started to have symptoms on 10-11-Feb-2021.) on 06-Feb-2021.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced FEELING ABNORMAL (they had a miserable night), ILLNESS (Sick whole day and night), NIGHT SWEATS (Had a night sweat), NAUSEA (nauseas) and PYREXIA (Fever). On 13-Apr-2021, the patient experienced SOMNOLENCE (Sleepy). On 14-Apr-2021, the patient experienced ASTHENIA (a little weak). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (they had a miserable night), ILLNESS (Sick whole day and night), NIGHT SWEATS (Had a night sweat), SOMNOLENCE (Sleepy), ASTHENIA (a little weak), NAUSEA (nauseas) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, SARS-CoV-2 test: positive (Positive) Infection with Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.      Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up was received on 4-AUG-2021 and contains second dose information and updated email address. On 05-Aug-2021: Follow-up was received on 6-AUG-2021 and contains no new Information.
gotten rash on chest and back; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 69-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EL3248 and expiration date: Unspecified), via an unspecified route of administration, administered in Arm Left on 11Feb2021 16:45 as SINGLE DOSE for covid-19 immunisation. Facility where most recent COVID-19 vaccine was administered was other. Medical history included pancreatic neuroendocrine tumour, benign prostatic hyperplasia. Concomitant medications received with 2 weeks of vaccination included tadalafil (TADALAFIL); tamsulosin (TAMSULOSIN); terbinafine (TERBINAFINE); ascorbic acid, ergocalciferol, folic acid, nicotinamide, panthenol, retinol, riboflavin, thiamine hydrochloride (MULTIVITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;FOLIC ACID;NICOTINAMIDE;PANTHENOL;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Reportedly, patient was not diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 since the vaccination. On 12Feb2021 the patient experienced rash on chest and back. Reportedly, patient had received 1st dose of covid vaccine week and half ago. After vaccine had gotten rash on chest and back. Patient wanted to know if it will be safe to get 2nd dose of vaccine. No treatment was received for the adverse event. The outcome of event was not recovered/not resolved on an unspecified date.  Follow-up attempts are completed. No further information is expected.
This spontaneous prospective pregnancy report was received from a certified medical assistant concerning a 19 year old female patient with no drug reactions/allergies. The patient's concurrent conditions and medical history were not reported. The patient went to see her gynecologist (name unspecified) on 23-FEB-2016 (the day before the vaccination), where she received an ultrasound, which revealed the pregnancy. It was reported that on 24-FEB-2016, the patient was vaccinated with a dose of GARDASIL 9, lot # L043213, expiration date: 28-AUG-2017, intramuscularly (dose not reported). Concomitant vaccine included MENACTRA. The physician was unaware that the patient was actually pregnant at the time of vaccination. The ultrasound was not sent to the primary care physician until 25-FEB-2016. No known adverse events. The last menstrual period (LMP) was on 06-NOV-2015 and estimated delivery date (EDD) was 12-AUG-2016. Follow up information has been received from a physician on 11-APR-2016. Her concurrent conditions included gravidity 2 and parity 2. She received a dose of GARDASIL on 30-JUL-2012. On 24-FEB-2016, she received a 0.5 ml dose of GARDASIL (not GARDASIL 9 as previously reported) lot# L018286, expiration date: 13-APR-2017. The patient did not tell that she was pregnant. It was found out several days later when a laboratory result came to the office. No treatment was required. Additional information is not expected as follow up information has been received. Patient's demographics, suspect therapy details and narrative were updated.
Patient had myalgias and diarrhea, presented to ED, found to have WBC count of 40.7 with elevated inflammatory markers. WBC returned to normal in 36 hours and inflammatory markers are downtrending.
Had 4th dose DTP 27FEB91-started a fever 100 about 7-8hrs p/vax; Given APAP & sponged about every 4 hrs on 1MAR91 @ 5AM had sz to ER, stayed 3hrs & d/c; Treated 6MAR91 URI, fever;
Tireness, Fatigue, Chills & Headaches. Took about 12 hours to run its course>
States he woke up shaking/"shivering" cold and felt hot at 120-130. Felt little dizzy/blurry getting up, hands tingling, legs felt numb. Had taken arthritis pain relief about 5 or 6 PM for HA. He was treated with Motrin and Tylenol, and NS IV. Discharged at 6:45 am.
Information has been received from a health professional concerning a 22 year old female who on 21-JUN-2007 was vaccinated with her first dose of Gardasil.  Concomitant therapy included ORTHO-CYCLEN.  On 27-DEC-2007 the patient was vaccinated with her third dose of Gardasil (lot# 659055/1522U).  On 08-JAN-2008 the patient experienced severe joint pain in lower extremities, pain in her ankle and in her foot.  The patient's severe joint pain in lower extremities, pain in her ankle and in her foot persisted.  She saw her family physician who told her to take ibuprofen (ADVIL).  She also had blood work done.  Additional information has been requested.
Fainting. Light headedness, 103.0 fever, malaise, blurred vision. body rash, brain fog and fatigue, I scheduled a Virtual Physician visit and was instructed to drink lots fluids and prescribed Steroid Cream for the body rash. These  symptoms lasted for 3 weeks after.  On  Sept 18th - I started experiencing  blurred vison, could not focus. I could barely able to open my eyes. I went to the Hospital due to  low blood pressure  and a rapid heart rate. I was admitted and stayed overnight for further testing . All COVID tests came back negative. I was prescribed Atenolol and discharged the next day.
Length of Stay:          Hospital Day(s): 6      CURRENT MEDICAL STATUS AND PLAN OF CARE Level of Care  | Level of Service LEVEL OF CARE: Levelofcare: ICU CLASS: inpatient Diagnosis HEMATURIA COVID-19 DISEASE  SYSTOLIC HEART FAILURE, CHRONIC  Status Post  ()    Discussed with Chart Review/Dr/(caregiver) Current Treatment Plan/ Plan of Care   - Salt and fluid restriction - Daily weights, strict I&O - Continue to monitor on telemetry    MSW referral initiated No Palliative Care referral initiated No    Additional Comments 9/30/ spoke to caregiver; unable to take patient back today due to personal at facility; explained patient medically cleared for DC; appeal DC. Can take patient back tomorrow.    DISCHARGE PLAN IM Reissue 9/30/23 Preferences Discussed Yes back to facility Anticipated DC Dispo Board and Care with HH Transportation at DC BLS DME Needs for DC n/a Teaching/ Learning Needs TBD Risk for readmission HIGH     PCC to Follow Clinical prgress for emerging DC planning needs.  Arrange transportation Appealed DC   RN  9/30/2023 2:22 PM            Note Details  Author RN File Time 10/2/2023  8:00 AM Author Type REGISTERED NURSE Status Signed Last Editor RN Specialty GENERAL, OTHER Admit Date 9/25/2023  ED to Hosp-Admission (Discharged) on 9/25/2023  ED to Hosp-Admission (Discharged) on 9/25/2023   Detailed Report  Note shared with patient Care Timeline  09/26   Transferred to ICU 2145   Admitted from ED (Observation) 2145 09/27   Admitted 1158    Transferred out of ICU 2025 10/01   Discharged 1515
Lost mobility in my right arm. Can not throw a ball anymore. Shoulder is painful in certain positions and I cannot sleep on. Started physical therpy this month (March 2010).
Hives throughout my body on 18th day after vaccine; given prednisone; On April 19th- developed terrible pain in both hands and fingers- as of now diagnosed as carpal syndrome